Literature DB >> 3024119

Model for alternative RNA processing in human calcitonin gene expression.

R A Bovenberg, W P van de Meerendonk, P D Baas, P H Steenbergh, C J Lips, H S Jansz.   

Abstract

The alternative RNA processing pathways in human calcitonin gene (CALC-I gene) expression were investigated using steady state RNA isolated from human medullary thyroid carcinoma (MTC) and from a culture line derived from this tumor. On Northern blots the mature 1.0 kilobases (Kb) calcitonin (CT) - and 1.1 Kb calcitonin gene-related peptide (CGRP) mRNAs were detected with CALCI gene specific probes as well as high molecular weight poly (A) containing RNAs of 2.1, 2.3, 3.3, 4.2, 5.0 and 5.7 Kb. The 5.7 Kb RNA was identified as the poly(A) tailed primary transcript containing sequences corresponding to all 6 exons and 5 introns of the CALC-I gene. From the composition of the other RNAs the splicing order of the different introns could be deduced. The results suggest the following model. First all introns not involved in alternative processing (introns 1, 2 and 5) are spliced from the 5.7 Kb RNA in rapid successive reactions yielding a 3.3 Kb RNA, which accumulates. From this 3.3 Kb RNA, the last common intermediate in the alternative processing pathway, CT mRNA is formed by splicing of intron 3 and poly(A) addition at exon 4, in this order or the reverse order via 2.3 Kb or 2.1 Kb RNA intermediates respectively. Alternatively, the whole intron 3-exon 4-intron 4 region is spliced from the 3.3 Kb RNA yielding CGRP mRNA. The temporal sequence of poly(A) addition at exons 4 and 6 may relate to the observed structural differences between the poly(A) addition signals at these sites. The ratio of CT- to CGRP mRNA may relate also to the differences in the primary structures of the intron 3- and intron 4 splice acceptor sites.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3024119      PMCID: PMC311911          DOI: 10.1093/nar/14.22.8785

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  53 in total

1.  Nuclear RNA precursors in the processing pathway to MOPC 21 kappa light chain messenger RNA.

Authors:  M Gilmore-Hebert; R Wall
Journal:  J Mol Biol       Date:  1979-12-25       Impact factor: 5.469

2.  The synthesis and processing of the messenger RNAs specifying heavy and light chain immunoglobulins in MPC-11 cells.

Authors:  U Schibler; K B Marcu; R P Perry
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

3.  Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.

Authors:  G K McMaster; G G Carmichael
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

4.  Splicing patterns of nuclear precursors to the mRNA for adenovirus 2 DNA binding protein.

Authors:  C J Goldenberg; H J Raskas
Journal:  Cell       Date:  1979-01       Impact factor: 41.582

5.  Steps in the processing of Ad2 mRNA: poly(A)+ nuclear sequences are conserved and poly(A) addition precedes splicing.

Authors:  J R Nevins; J E Darnell
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

6.  Processing of the mouse beta-globin mRNA precursor: at least two cleavage-ligation reactions are necessary to excise the larger intervening sequence.

Authors:  A J Kinniburgh; J Ross
Journal:  Cell       Date:  1979-08       Impact factor: 41.582

7.  Structure of late adenovirus 2 heterogeneous nuclear RNA.

Authors:  S M Berget; P A Sharp
Journal:  J Mol Biol       Date:  1979-04-25       Impact factor: 5.469

8.  The synthesis and processing of a nuclear RNA precursor to rat pregrowth hormone messenger RNA.

Authors:  M M Harpold; P R Dobner; R Evans; F C Bancroft; J E Darnell
Journal:  Nucleic Acids Res       Date:  1979-07-11       Impact factor: 16.971

9.  Cell-specific expression of secreted versus membrane forms of immunoglobulin gamma 2b mRNA involves selective use of alternate polyadenylation sites.

Authors:  C Milcarek; B Hall
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  14 in total

1.  A nuclear function of Hu proteins as neuron-specific alternative RNA processing regulators.

Authors:  Hui Zhu; Robert A Hasman; Victoria A Barron; Guangbin Luo; Hua Lou
Journal:  Mol Biol Cell       Date:  2006-10-11       Impact factor: 4.138

2.  Hybridohistochemical demonstration of alternative splicing of the CALC-I gene.

Authors:  M Denijn; R A De Weger; C J Lips; J A Van Unnik; W Den Otter
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

3.  Validation of an in vitro RNA processing system for CT/CGRP precursor mRNA.

Authors:  G J Cote; I N Nguyen; C J Lips; S M Berget; R F Gagel
Journal:  Nucleic Acids Res       Date:  1991-07-11       Impact factor: 16.971

Review 4.  Peptides from the calcitonin genes: molecular genetics, structure and function.

Authors:  L H Breimer; I MacIntyre; M Zaidi
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

5.  Altered calcitonin gene in a young patient with osteoporosis.

Authors:  M Alevizaki; J C Stevenson; S I Girgis; I MacIntyre; S Legon
Journal:  BMJ       Date:  1989-05-06

6.  In vitro splicing pathways of pre-mRNAs containing multiple intervening sequences?

Authors:  K M Lang; R A Spritz
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

7.  Uridine branch acceptor is a cis-acting element involved in regulation of the alternative processing of calcitonin/CGRP-l pre-mRNA.

Authors:  G J Adema; K L van Hulst; P D Baas
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

8.  Model for tissue specific Calcitonin/CGRP-I RNA processing from in vitro experiments.

Authors:  R A Bovenberg; G J Adema; H S Jansz; P D Baas
Journal:  Nucleic Acids Res       Date:  1988-08-25       Impact factor: 16.971

9.  Unusual branch point selection involved in splicing of the alternatively processed Calcitonin/CGRP-I pre-mRNA.

Authors:  G J Adema; R A Bovenberg; H S Jansz; P D Baas
Journal:  Nucleic Acids Res       Date:  1988-10-25       Impact factor: 16.971

Review 10.  Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs.

Authors:  Jonathan Jia Yuan Ong; Diana Yi-Ting Wei; Peter J Goadsby
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.